ArticleCurrent oncology (Toronto, Ont.)2024

Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort.

Simon Nannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.